
NanoVibronix NAOV
Quarterly report 2025-Q3
added 11-14-2025
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
270 K |
Market Cap[1] |
$ 1.08 M |
EBITDA (LTM) |
$ -5.08 M |
P/E (LTM) |
- |
P/S (LTM) |
0.41 |
EPS (LTM) |
-32.68 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Abbott Laboratories
ABT
|
$ 102.18 | -0.67 % | $ 178 B | NYSE,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 11.98 | -0.42 % | $ 1.62 B | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 170.34 | -0.15 % | $ 12.8 B | Nasdaq Global Select Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.68 | -0.14 % | $ 151 M | Nasdaq Global Select Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Alphatec Holdings
ATEC
|
$ 10.86 | 0.28 % | $ 1.63 B | Nasdaq Global Select Market | ||
|
AxoGen
AXGN
|
$ 33.95 | -1.44 % | $ 1.56 B | Nasdaq Capital Market,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Butterfly Network
BFLY
|
$ 4.13 | 0.49 % | $ 874 M | NYSE | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 36.83 | 0.19 % | $ 5.49 K | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 62.71 | -0.18 % | $ 92.8 B | NYSE,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
ClearPoint Neuro
CLPT
|
$ 9.42 | 0.53 % | $ 267 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 34.68 | -0.32 % | $ 1.08 B | NYSE,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.6 | 2.92 % | $ 37.3 M | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 9.75 | 1.25 % | $ 349 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.38 | -0.44 % | $ 127 M | Nasdaq Global Market | ||
|
Electromed
ELMD
|
$ 23.29 | - | $ 197 M | NYSE American | ||
|
Edwards Lifesciences Corporation
EW
|
$ 80.81 | -0.3 % | $ 47.3 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.58 | -0.05 % | $ 122 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 87.99 | 0.08 % | $ 11.9 B | NYSE,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Helius Medical Technologies
HSDT
|
$ 1.96 | 5.52 % | $ 1.19 M | Nasdaq Capital Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 9.46 | -0.73 % | $ 729 M | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Inogen
INGN
|
$ 6.24 | 0.48 % | $ 166 M | Nasdaq Global Select Market,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 56.41 | 2.58 % | $ 1.66 B | NYSE,SPB | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.0 | 2.52 % | $ 16.9 M | Nasdaq Global Select Market | ||
|
IRadimed Corporation
IRMD
|
$ 95.03 | -1.25 % | $ 1.21 B | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.96 | -1.02 % | $ 2.99 B | NYSE,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.06 | - | $ 377 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 6.09 | 0.5 % | $ 72.8 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.